Mahesh Kumar Teli

669 total citations
24 papers, 527 citations indexed

About

Mahesh Kumar Teli is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Mahesh Kumar Teli has authored 24 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Cancer Research. Recurrent topics in Mahesh Kumar Teli's work include Metabolomics and Mass Spectrometry Studies (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Synthesis and biological activity (5 papers). Mahesh Kumar Teli is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Synthesis and biological activity (5 papers). Mahesh Kumar Teli collaborates with scholars based in India, South Korea and Germany. Mahesh Kumar Teli's co-authors include G. K. Rajanikant, Srinivas Mutalik, Mi‐Hyun Kim, Surendra Kumar, Dharmendra Kumar Yadav, Dirk M. Hermann, Mathias Bähr, Britta Kaltwasser, Thorsten R. Doeppner and Syam Nair and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Experimental Neurology.

In The Last Decade

Mahesh Kumar Teli

24 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahesh Kumar Teli India 13 257 97 71 62 54 24 527
John Eldredge United States 11 588 2.3× 84 0.9× 81 1.1× 63 1.0× 40 0.7× 14 1.0k
Suzana Aulić Italy 14 351 1.4× 55 0.6× 48 0.7× 21 0.3× 28 0.5× 24 618
Fernanda Faião‐Flores Brazil 18 480 1.9× 42 0.4× 60 0.8× 58 0.9× 43 0.8× 32 860
Nahlah Makki Almansour Saudi Arabia 13 262 1.0× 48 0.5× 31 0.4× 87 1.4× 63 1.2× 27 565
Yu Luo China 16 463 1.8× 94 1.0× 161 2.3× 92 1.5× 22 0.4× 59 920
Dian Xiao China 15 262 1.0× 59 0.6× 72 1.0× 28 0.5× 59 1.1× 26 706
Hovhannes J. Gukasyan United States 17 268 1.0× 31 0.3× 49 0.7× 23 0.4× 39 0.7× 42 759
Ahil N. Ganesh Canada 11 211 0.8× 47 0.5× 53 0.7× 16 0.3× 96 1.8× 13 481
Bahram Goliaei Iran 16 282 1.1× 27 0.3× 30 0.4× 38 0.6× 102 1.9× 57 652
Antonino N. Fallica Italy 9 220 0.9× 20 0.2× 46 0.6× 46 0.7× 76 1.4× 17 373

Countries citing papers authored by Mahesh Kumar Teli

Since Specialization
Citations

This map shows the geographic impact of Mahesh Kumar Teli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahesh Kumar Teli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahesh Kumar Teli more than expected).

Fields of papers citing papers by Mahesh Kumar Teli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahesh Kumar Teli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahesh Kumar Teli. The network helps show where Mahesh Kumar Teli may publish in the future.

Co-authorship network of co-authors of Mahesh Kumar Teli

This figure shows the co-authorship network connecting the top 25 collaborators of Mahesh Kumar Teli. A scholar is included among the top collaborators of Mahesh Kumar Teli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahesh Kumar Teli. Mahesh Kumar Teli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teli, Mahesh Kumar, et al.. (2025). Identification of KMH-45, a novel MRGPRX2 inhibitor with enhanced anti-pruritic properties. Biomedicine & Pharmacotherapy. 190. 118371–118371. 1 indexed citations
2.
Kumar, Surendra, Mahesh Kumar Teli, & Mi‐Hyun Kim. (2024). GPCR-IPL score: multilevel featurization of GPCR–ligand interaction patterns and prediction of ligand functions from selectivity to biased activation. Briefings in Bioinformatics. 25(2). 4 indexed citations
3.
Teli, Mahesh Kumar, et al.. (2021). Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space. European Journal of Medicinal Chemistry. 227. 113880–113880. 4 indexed citations
4.
Teli, Mahesh Kumar, Surendra Kumar, Dharmendra Kumar Yadav, & Mi‐Hyun Kim. (2021). In silico identification of prolyl hydroxylase inhibitor by per‐residue energy decomposition‐based pharmacophore approach. Journal of Cellular Biochemistry. 122(9). 1098–1112. 11 indexed citations
5.
Teli, Mahesh Kumar, Surendra Kumar, Dharmendra Kumar Yadav, & Mi‐Hyun Kim. (2020). In silico identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitor. Journal of Biomolecular Structure and Dynamics. 39(2). 703–717. 12 indexed citations
6.
Subedi, Lalita, et al.. (2020). Positioning of an unprecedented spiro[5.5]undeca ring system into kinase inhibitor space. Scientific Reports. 10(1). 21265–21265. 10 indexed citations
7.
Yadav, Dharmendra Kumar, Surendra Kumar, Saloni Saloni, et al.. (2018). Molecular Insights into the Interaction of RONS and Thieno[3,2-c]pyran Analogs with SIRT6/COX-2: A Molecular Dynamics Study. Scientific Reports. 8(1). 4777–4777. 58 indexed citations
8.
Venkatesan, Gnanavel, et al.. (2017). Expression and evaluation of recombinant P32 protein based ELISA for sero-diagnostic potential of capripox in sheep and goats. Molecular and Cellular Probes. 37. 48–54. 24 indexed citations
9.
Teli, Mahesh Kumar, et al.. (2016). β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions. European Journal of Pharmacology. 791. 405–411. 8 indexed citations
10.
Doeppner, Thorsten R., Britta Kaltwasser, Mahesh Kumar Teli, et al.. (2015). Post-stroke transplantation of adult subventricular zone derived neural progenitor cells — A comprehensive analysis of cell delivery routes and their underlying mechanisms. Experimental Neurology. 273. 45–56. 27 indexed citations
11.
12.
Teli, Mahesh Kumar & G. K. Rajanikant. (2013). A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors. Medicinal Chemistry. 9(3). 360–370. 9 indexed citations
13.
Teli, Mahesh Kumar & G. K. Rajanikant. (2013). Computational Repositioning and Experimental Validation of Approved Drugs for HIF-Prolyl Hydroxylase Inhibition. Journal of Chemical Information and Modeling. 53(7). 1818–1824. 13 indexed citations
14.
Teli, Mahesh Kumar & G. K. Rajanikant. (2012). Pharmacophore generation and atom-based 3D-QSAR of N-iso-propyl pyrrole-based derivatives as HMG-CoA reductase inhibitors. PubMed. 2(1). 25–25. 35 indexed citations
15.
Teli, Mahesh Kumar, et al.. (2012). Generation of Pharmacophore and Atom Based 3D-QSAR Model of Novel Isoquinolin-1-one and Quinazolin-4-one-type Inhibitors of TNFα. Medicinal Chemistry. 8(3). 436–451. 6 indexed citations
16.
Teli, Mahesh Kumar, et al.. (2012). Pharmacophore Generation and 3D-QSAR of Novel 2-(quinazolin-4- ylamino)-[1,4] Benzoquinone Derivatives as VEGFR-2 Inhibitors. Letters in Drug Design & Discovery. 9(10). 899–914. 4 indexed citations
17.
Nair, Syam, et al.. (2012). Computational identification of novel histone deacetylase inhibitors by docking based QSAR. Computers in Biology and Medicine. 42(6). 697–705. 36 indexed citations
18.
Teli, Mahesh Kumar & G. K. Rajanikant. (2011). Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening. Molecular Diversity. 16(1). 193–202. 15 indexed citations
19.
Teli, Mahesh Kumar & G. K. Rajanikant. (2011). Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 27(4). 558–570. 21 indexed citations
20.
Teli, Mahesh Kumar, Srinivas Mutalik, & G. K. Rajanikant. (2010). Nanotechnology and Nanomedicine: Going Small Means Aiming Big. Current Pharmaceutical Design. 16(16). 1882–1892. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Eldredge Breakdown of academic impact, for papers by Suzana Aulić Breakdown of academic impact, for papers by Fernanda Faião‐Flores Breakdown of academic impact, for papers by Nahlah Makki Almansour Breakdown of academic impact, for papers by Yu Luo Breakdown of academic impact, for papers by Dian Xiao Breakdown of academic impact, for papers by Hovhannes J. Gukasyan Breakdown of academic impact, for papers by Ahil N. Ganesh Breakdown of academic impact, for papers by Bahram Goliaei Breakdown of academic impact, for papers by Antonino N. Fallica
Rankless by CCL
2026